Stockholders’ Equity |
9 Months Ended |
|---|---|
Jun. 30, 2024 | |
| Equity [Abstract] | |
| Stockholders’ Equity |
Note 8 - Stockholders’ Equity
Dividends
No dividends were declared or paid during the three and nine months ended June 30, 2024 or the twelve months ended October 1, 2023.
Common Stock
On September 22, 2021, the Company announced authorization of a $1 million stock repurchase program. The shares authorized to be repurchased under the repurchase program may be purchased from time to time at prevailing market prices, through open market transactions or in negotiated transactions, depending upon market conditions and subject to Rule 10b-18 as promulgated by the SEC.
During the three and nine months ended July 2, 2023 and June 30, 2024, there were zero common shares repurchased under the program.
During the three and nine months ended June 30, 2024, the Company issued 20,426 and 101,718 shares to Danny Schoening and Karen Hawkins in settlement of 27,000 and 135,000 performance shares, which vested during the three and nine months, respectively. The shares were issued net of 6,574 and 33,282 shares withheld for taxes.
During the three and nine months ended June 30, 2024, the Company issued 8,446 shares to ten employees in settlement of 12,000 restricted stock units, which vested during the three and nine months. The shares were issued net of 3,554 shares withheld for taxes.
As of June 30, 2024 and October 1, 2023, total outstanding common shares were 6,873,234 and 6,763,070, respectively.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|